CSIMarket


Mylan N v   (MYL)
Other Ticker:  
 

Mylan N v

MYL's Fundamental analysis








Looking into Mylan N V growth rates, revenue grew by 0.35 % in III. Quarter 2020 from the same quarter a year ago. Ranking at No. 1943

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.61 %

Mylan N V 's net profit deacreased by -2.16 % in III. Quarter 2020 year on year, to $186 millions.

More on MYL's Growth


Mylan N V
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Mylan N V PEG ratio is at 6.26 Company is currently trading with Price to Cash flow multiple of 29.55 in trailing twelve-month period.
Company
32.15
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.49.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.5.


More on MYL's Valuation
 
 Total Debt (Millions $) 12,340
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 481,751
 Net Income/Employee (TTM) $ 7,611
 Receivable Turnover (TTM) 5.84
 Tangible Book Value (Per Share $) -15.91

Mylan N V
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Mylan N V PEG ratio is at 6.26 Company is currently trading with Price to Cash flow multiple of 29.55 in trailing twelve-month period.
Company
32.15
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.49.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.5.

Mylan N V Price to Book Ratio is at 0.65 lower than Indusry Avg. of 1328.55. and higher than S&P 500 Avg. of -0.01

More on MYL's Valuation

  Market Capitalization (Millions $) 8,208
  Shares Outstanding (Millions) 518
  Employees 35,000
  Revenues (TTM) (Millions $) 16,861
  Net Income (TTM) (Millions $) 266
  Cash Flow (TTM) (Millions $) 278
  Capital Exp. (TTM) (Millions $) -200
  Total Debt (Millions $) 12,340
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 481,751
  Net Income/Employee(TTM) $ 7,611
  Receivable Turnover Ratio (TTM) 5.84
  Tangible Book Value (Per Share $) -15.91

  Market Capitalization (Millions $) 8,208
  Shares Outstanding (Millions) 518
  Employees 35,000
  Revenues (TTM) (Millions $) 16,861
  Net Income (TTM) (Millions $) 266
  Cash Flow (TTM) (Millions $) 278
  Capital Exp. (TTM) (Millions $) -200


    MYL's Profitability Comparisons
Mylan N V achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2020 to 11.82 % from 4.91 % in II. Quarter.

Mylan N V net profit margin of 6.25 % is currently ranking no. 49 in Major Pharmaceutical Preparations industry, ranking no. 157 in Healthcare sector and number 1816 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 1.01
  Total Debt to Equity (MRQ) 0.98
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.55
  Inventory Turnover Ratio (TTM) 3.94



Mylan N V achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2020 to 11.82 % from 4.91 % in II. Quarter.

Mylan N V net profit margin of 6.25 % is currently ranking no. 49 in Major Pharmaceutical Preparations industry, ranking no. 157 in Healthcare sector and number 1816 in S&P 500.

More on MYL's Key Ratios



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MRJT's Profile

Stock Price

MRJT's Financials

Business Description

Fundamentals

Charts & Quotes

MRJT's News

Suppliers

MRJT's Competitors

Customers & Markets

Economic Indicators

MRJT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071